AOD 9604 Side Effects and Liver Health: What the Research Says

AOD-9604 has not been shown to cause liver damage in human clinical trials. Published studies report side effects similar to placebo, and no liver-related safety signals have been identified. Still, AOD-9604 is not FDA-approved for human use, and long-term liver data does not exist.

What Is AOD-9604 and How Does It Work?

AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH), specifically the C-terminal region known as hGH 176-191. Researchers developed it to isolate the fat-metabolizing effects of hGH while avoiding its effects on growth and blood sugar.

The peptide is studied for fat loss and metabolic health, but it has not been approved by the FDA for any human indication. AOD-9604 is sold as a research chemical, which means quality and purity vary widely.

Understanding aod 9604 effects starts with recognizing that published human data is limited to a handful of short-term trials.

Does AOD-9604 Affect the Liver? What the Research Shows

Human trials of AOD-9604 have not reported liver toxicity. In a Phase IIb study of more than 500 participants, adverse events were comparable between the peptide and placebo groups, with no notable changes in liver enzymes.

That is different from full-growth-hormone therapy. hGH can rarely cause elevated liver enzymes or other hepatic issues, especially at high doses. AOD-9604 is a fragment and does not activate the hGH receptor the same way, which lowers the theoretical risk to the liver.

Feature	Full hGH	AOD-9604
Receptor activation	Full hGH receptor	Limited or partial
IGF-1 increase	Yes	No significant increase
Liver enzyme changes	Possible at high doses	Not reported in trials
FDA approved	Yes, for specific conditions	No
Human safety data	Extensive	Limited

An important limitation is that most AOD-9604 studies lasted 12 to 24 weeks. There is no long-term data on liver health, and no studies have focused on people with existing liver disease.

Common Side Effects of AOD-9604

Reported side effects are generally mild. In clinical trials, the most common complaints included:

• Injection site reactions such as redness, pain, or swelling
• Headache
• Nausea
• Fatigue
• Mild dizziness

Many online reports of severe side effects come from unregulated products rather than pharmaceutical-grade peptide. When reading about aod 9604 benefits and side effects, consider whether the source distinguishes clinical trial data from anecdotal user reports.

No liver-specific side effects have been documented in peer-reviewed human studies of AOD-9604.

How AOD-9604 Compares to Other Compounds for Liver Risk

People often research AOD-9604 alongside other peptides and weight-loss drugs. Liver considerations differ by compound.

Compound	Liver-related concerns	Human data
AOD-9604	No liver injury reported in trials	Limited and short-term
BPC-157	No consistent liver toxicity in human data; mostly animal studies	Very limited
5-amino-1MQ	No human liver safety data; animal studies only	Preclinical
Tirzepatide with AOD-9604	Tirzepatide alone can rarely affect liver enzymes; combination is unstudied	Tirzepatide studied alone

Researchers looking into bpc 157 side effects liver will find mostly preclinical data, with some animal studies suggesting possible protection rather than harm. Similarly, 5-amino-1mq side effects liver is an open question because human trials have not been conducted.

When people search for aod 9604 and tirzepatide together side effects, the honest answer is that no clinical trial has tested this combination. Tirzepatide alone can cause nausea, diarrhea, and rarely pancreatitis or gallbladder issues; adding an unapproved peptide increases unknown risks.

Who Should Be Cautious About AOD-9604 and Liver Health?

AOD-9604 is not appropriate for everyone. Extra caution is warranted for:

• People with existing liver disease, hepatitis, or cirrhosis
• People who drink alcohol heavily
• People taking medications that can stress the liver, such as high-dose acetaminophen, certain antibiotics, or methotrexate
• Anyone considering unapproved peptide protocols without medical supervision

If you decide to use AOD-9604, baseline and periodic liver function tests (ALT, AST, bilirubin) are reasonable precautions. Discuss any new supplement or peptide with your healthcare provider, especially if you have liver conditions.

AOD-9604 is not a treatment for fatty liver disease, obesity, or any liver condition.

The Bottom Line on AOD-9604 and Liver Safety

AOD-9604 has not been linked to liver damage in published human trials. The peptide appears to have a low theoretical risk for hepatotoxicity because it does not act like full growth hormone. However, the absence of evidence is not proof of long-term safety.

AOD-9604 is not FDA-approved for human use in the United States. Sale as a research chemical means no guarantee of purity, dose accuracy, or sterility. Anyone with liver concerns should prioritize medical evaluation over internet claims.

COMMON QUESTIONS

Frequently Asked Questions

Can AOD 9604 cause liver damage?

Human trials have not shown AOD-9604 to cause liver damage. No liver-related side effects were reported in published short-term studies. However, long-term safety data is missing, and the peptide is not FDA-approved for human use.

Does AOD 9604 raise liver enzymes?

Published clinical trials have not reported significant increases in ALT, AST, or other liver enzymes with AOD-9604. Still, individual responses vary, and periodic bloodwork is the only way to know how your liver responds. Talk to a healthcare provider before using it.

Is AOD 9604 safe to combine with other peptides or weight-loss drugs?

No human studies have tested AOD-9604 combined with tirzepatide, BPC-157, or other compounds. Combinations increase the risk of unknown interactions and side effects. A healthcare professional can help assess your specific situation.